Dr. John Monahan, PhD. , part of GKA Board, founded and built Avigen inc.
http:// www.gkat.ie/Board.html
Avigen inc, working towards gene therapy for hemophilia B, also procured by bayer, whom invested $15mm in company, additional investment of $60mm for Research.
https:// www.nytimes.com/2000/11/17/business/technology-briefing-biotechnology-bayer-to-sell-gene-therapy.html?rref=collection%2Ftimestopic%2FAvigen%20Inc.&action=click&contentCollection=business®ion=stream&module=stream_unit&version=latest&contentPlacement=1&pgtype=collection
Bayer is into everything…. just trails built on by Anon, took 3-5 min to research.
To add to that: avigen inc. is traded publicly, but doesn't seem to have a website…. avigen.com for sale
https:// www.nasdaq.com/markets/spos/company/avigen-inc-de-1254-50068 (website listed in full description when expanded)
When looked into, the name Ken chahine pops up as CEO in Nasdaq
https:// www.huffingtonpost.com/author/dr-ken-chahine-phd-jd
One search later…
"Ken Chahine has served as Senior Vice President and General Manager for Ancestry.com DNA, LLC since 2011. Prior to joining Ancestry.com, Ken held several positions, including Chief Executive Officer of Avigen, a biotechnology company in the Department of Human Genetics at the University of Utah, and at Parke-Davis Pharmaceuticals (currently Pfizer). Ken also teaches a course focused on new venture development, intellectual property and licensing at the University of Utah's College of Law. He earned a Ph.D. in Biochemistry from the University of Michigan, a J.D. from the University of Utah College of Law and a B.A. in Chemistry from Florida State University."
Hurrrrrrrm